HomeRKDA • NASDAQ
add
Arcadia Biosciences Inc
Previous close
$3.48
Day range
$3.35 - $3.51
Year range
$1.87 - $10.31
Market cap
4.64M USD
Avg Volume
5.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.54M | 18.41% |
Operating expense | 2.24M | 20.32% |
Net income | -1.61M | 37.20% |
Net profit margin | -104.88 | 46.97% |
Earnings per share | -0.87 | — |
EBITDA | -1.75M | -34.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.58M | -58.11% |
Total assets | 15.24M | -35.05% |
Total liabilities | 5.09M | -36.89% |
Total equity | 10.15M | — |
Shares outstanding | 1.36M | — |
Price to book | 0.46 | — |
Return on assets | -26.99% | — |
Return on capital | -38.88% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.61M | 37.20% |
Cash from operations | -1.75M | 39.27% |
Cash from investing | 180.00K | 3,500.00% |
Cash from financing | 4.00K | -42.86% |
Net change in cash | -1.57M | 45.42% |
Free cash flow | 3.25M | 6,857.40% |
About
Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.
It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought. Wikipedia
Founded
2002
Headquarters
Website
Employees
21
